1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Exploring Definitions and Predictors of Response to Biologics for Severe Asthma
2024) In Journal of Allergy and Clinical Immunology: In Practice(
- Contribution to journal › Article
- 2023
-
Mark
Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both
(
- Contribution to journal › Article
- 2022
-
Mark
House dust mite sensitization and exposure affects bronchial epithelial anti-microbial response to viral stimuli in patients with asthma
(
- Contribution to journal › Article
-
Mark
Altered viral resistance and tolerance as pathogenic mechanisms of allergic airway inflammation
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2021
-
Mark
Risk of Rehospitalization and Death in Patients Hospitalized Due to Asthma
(
- Contribution to journal › Article
- 2019
-
Mark
IL-33 drives influenza-induced asthma exacerbations by halting innate and adaptive antiviral immunity
(
- Contribution to journal › Article
-
Mark
IL-33 blockade affects mediators of persistence and exacerbation in a model of chronic airway inflammation
(
- Contribution to journal › Article
- 2018
-
Mark
On causes and regulation of anti-viral defence in asthma and COPD
(
- Thesis › Doctoral thesis (compilation)
-
Mark
The interplay between immune response and bacterial infection in COPD : Focus Upon non-typeable Haemophilus influenzae
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD : FLAME-based modelling in a Swedish population
(
- Contribution to journal › Article